22 December 2022 - This recommendation comes from a pilot to develop simpler, faster evaluations for the appraisal of some treatments.
Children being treated for growth disturbance could be spared the pain and discomfort caused by daily injections after NICE recommended a new weekly treatment option called somatrogon.